title: DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells.
abstract: Nasopharyngeal carcinoma-associated gene 6 (NGX6) is a novel candidate tumor metastasis suppressor gene. Our study was to determine whether DNA hypermethylation and histone modification at the NGX6 gene promoter play important roles in silencing NGX6 expression in gastric cancer. NGX6 expression was downregulated in all gastric cancer cells and 76.19 % tissues. In three GC cell lines, hypermethylated NGX6 loci were characterized by histone H3-K9 hypoacetylation and hypermethylation. Trichostatin A treatment could moderately increase H3-K9 acetylation at the silenced loci; however, it had no effect on DNA and H3-K9 methylation and minimal effects on NGX6 expression. In contrast, 5'aza-2'-deoxycytidine treatment could rapidly decrease DNA and H3-K9 methylation at the silenced loci, leading to the reexpression of NGX6. Combined treatment with 5'aza-2'-deoxycytidine and trichostatin A had synergistic effects on the reexpression of NGX6 at the hypermethylation loci. Our current study shows that NGX6 expression is downregulated in GC cancer cells and tissues due to NGX6 promoter methylation and H3-K9 methylation, but not H3-K9 acetylation. Our findings indicate that the downregulation of NGX6 expression contributes to the development and progression of gastric cancer. More studies are needed to determine the precise mechanism of NGX6 in the progression of gastric cancer.
authors: Department of Gastrointedtinal Surgery and Cancer Center, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China.
authors: Jian
authors: J
authors: Liu
authors: Xinjiang
authors: X
authors: Zhu
authors: Xiaoyang
authors: X
authors: Xu
authors: Dongqiu
authors: D
authors: Dai
mesh_terms: D045744:Cell Line, Tumor; D002470:Cell Survival; D003094:Collagen / Q000737:chemistry; D019175:DNA Methylation; D015536:Down-Regulation; D004338:Drug Combinations; D015972:Gene Expression Regulation, Neoplastic; D056572:Histone Deacetylase Inhibitors / Q000737:chemistry; D006657:Histones / Q000378:metabolism*; D006801:Humans; D006877:Hydroxamic Acids / Q000737:chemistry; D007797:Laminin / Q000737:chemistry; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D009362:Neoplasm Metastasis; D011401:Promoter Regions, Genetic; D011509:Proteoglycans / Q000737:chemistry; D013274:Stomach Neoplasms / Q000235:genetics* / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D004338:Drug Combinations; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D007797:Laminin; D008565:Membrane Proteins; D011509:Proteoglycans; C477325:TMEM8B protein, human; D025521:Tumor Suppressor Proteins; C059485:matrigel; C012589:trichostatin A; D003094:Collagen